Sorafenib Completed Phase 1 Trials for Hepatocellular Cancer / Liver Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01075113Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer
NCT01011010Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
NCT02069145Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
NCT00997022Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients